Ani Pharmaceuticals (NASDAQ: ANIP ) should raise 2025 guidance on May 9, 2025, based on the FDA approval of Purified Cortrophin Gel syringe and the marketing of two recently approved NDA's, INZIRQO and I am presently working on a concept, I call investigative investing. A labor intensive exercise that combines investigative experience with mass collaboration in order to identify grossly undervalued stocks that are sitting on significant price moving information. It is a work in progress. Seeking Alpha's Dis ...